Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00621179Phase 4Completed
Phase 4, randomised, open-label trial of leuprolide in endometriosis (4 arms), sponsored by CCRM Fertility. Primary endpoint: Patients Who Responded to Controlled Ovarian Hyperstimulation at 6.5 weeks. Started Mar 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00621179.